Optimal anticoagulation strategy for left ventricular assist device patients undergoing thoracentesis: a retrospective study

Back

ESC Professional Premium Access

Optimal anticoagulation strategy for left ventricular assist device patients undergoing thoracentesis: a retrospective study

Session: Devices in heart failure: new findings

Topic: Ventricular Assist Devices

Speaker: Doctor S. Hegde (Houston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Sharana Hegde

Baylor College of Medicine, Houston (United States of America)

0 follower

7 more presentations in this session

Predictors of Right vEntricular Failure aftER LVAD implantation: PREFER LVAD study

Speaker: Associate Professor M. Cameli (Siena, IT)

Elevated cancer biomarkers in patients with severe heart failure could be a potential predictor of mortality during LVAD support

Speaker: Doctor A. Bielka (Zabrze, PL)

Right ventricular failure following left ventricular assist device implantation.

Speaker: Associate Professor M. Laimoud (Riyadh, SA)

A meta-analysis of the efficacy and safety of exercise-based cardiac rehabilitation in patients with left ventricular assist devices.

Speaker: Doctor M. Abouzid (Poznan, PL)

Impact of digoxin on gastrointestinal bleeding following left ventricular assist device implantation: a systematic review and meta-analysis

Speaker: Doctor H. Alani (Doha, QA)

Access the full session

Devices in heart failure: new findings

Speakers: Doctor S. Hegde, Associate Professor M. Cameli, Doctor A. Bielka, Associate Professor M. Laimoud, Doctor M. Abouzid...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources